Healthlead Public Company Limited
HL
Rank in Stocks
#24296
Healthlead Public Company Limited, along with its subsidiaries, specializes in... Healthlead Public Company Limited, along with its subsidiaries, specializes in the creation, sourcing, and distribution of a wide array of health-related goods. This portfolio encompasses pharmaceuticals, medicinal preparations, beauty aids, nutritional supplements, and medical devices. Their offerings also include hygiene products like disinfectants and deodorizers, notably masks, sold under brand names such as iCare, Pharmax, vitaminclub, and Super Drug. Furthermore, nutritional supplements are marketed under the PRIME and Besuto brands. Diversifying its operations, the company engages in property leasing, event planning, restaurant management, and operates its own medical clinic. It maintains a retail footprint through 28 pharmacy locations: 11 iCare, 13 Pharmax, 3 vitaminclub, and 1 Super Drug. The company was founded in 2018 and has its principal office in Nonthaburi, Thailand.
Share Price
$0.13474869
Last synced: 2026-11-10
Market Cap
$34.24M
Change (1 day)
0.00%
Change (1 year)
-39.84%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Healthlead Public Company Limited (HL)
Category
Healthcare
EPS for Healthlead Public Company Limited (HL)
EPS as of June 2026 TTM: $0.01
According to Healthlead Public Company Limited's latest financial reports, its current EPS (TTM) is $0.01. At the end of 2025 the company had an EPS of $0.01, equal to its 2024 EPS of $0.01.
EPS history for Healthlead Public Company Limited from 2017 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.01 | -35.00% |
| 2025 | $0.01 | 8.24% |
| 2024 | $0.01 | 8.97% |
| 2023 | $0.01 | -37.10% |
| 2022 | $0.01 | 5.98% |
| 2021 | $0.01 | 85.71% |
| 2020 | $0.01 | 133.33% |
| 2019 | 0.00 | 0.00% |
| 2018 | 0.00 | -100.00% |
| 2017 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $39.05 | 600,669.23% |
US
|
|
| $17.99 | 276,669.23% |
US
|
|
| $7.77 | 119,438.46% |
US
|
|
| $17.99 | 276,669.23% |
US
|
|
| $0.04 | 569.23% |
AU
|
Questions about Healthlead Public Company Limited's earnings per share (EPS)
What is Healthlead Public Company Limited's earnings per share (EPS)?
Healthlead Public Company Limited's earnings per share (EPS) over the last twelve months is $0.01, as of Jun 2026.
What was Healthlead Public Company Limited's earnings per share (EPS) in 2025?
In 2025, Healthlead Public Company Limited's earnings per share (EPS) was $0.01, about the same as in 2024 ($0.01).
How has Healthlead Public Company Limited's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Healthlead Public Company Limited's earnings per share (EPS) went from $0.01 to $0.01, an average growth of 0.00% a year.
How does Healthlead Public Company Limited's earnings per share (EPS) compare with similar companies?
Healthlead Public Company Limited's earnings per share (EPS) ($0.01) is lower than that of all 5 similar companies listed above. The highest among them is McKesson Corporation, with $39.05.